From software exits to real asset overweights, James Rodda explains the trades, risks and themes shaping Antipodes’ portfolio ...

Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT ...

The Company reported over NIS 270 million in revenue, NIS 37 million in Net loss, NIS 47 million in Adjusted EBITDA and NIS 17 million in positive operating cash flow, reflecting strong resilience and ...

With the 2025-26 NBA regular season in the rearview mirror, it's now time to look back and reflect on all that the 2025 ...

Bold predictions for the 49ers' 2026 NFL Draft class, featuring WR De'Zhaun Stribling and CB Ephesians Prysock ...

The Kansas City Chiefs had clear defensive holes on the defensive line and in the secondary heading into the 2026 NFL draft.

A pro explains how to change your oil at home in under an hour.

YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced its ...